TrialEuropean journal of neurology2025

Improvement in Patient-Reported Symptoms of Generalised Myasthenia Gravis With Rozanolixizumab in the Randomised Phase 3 MycarinG Study Using the MG Symptoms PRO.

Henry J Kaminski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.